ã¯ã¬ã¢ãã³ã£ãŠãçµå±ãçãã¬ã®äººãã ãã®ãã®ïŒ
ããã¥ããã¹ã®èŠç¹ã§æ£ã®åã®çåã«çããŠã¿ã
ã€ãæè¿ã§ããããªãŒã¹ãã©ãªã¢ã§
ãã¯ã¬ã¢ãã³ããã¬ã€ã³ãã©ã°ã«å¹ãã
ãšããããã¥ãŒã¹ãå ±ããããŠããŸããã
ç§ãå€ããè¬å±ã®æ£ã«ãã
ãŸãã§æ¥æ¬ã®ãã€ã³ãã»ãŒã«ã®ããã«ã
æ°ãããã©ã³ãã®ã¯ã¬ã¢ãã³ãããããšäžŠãã§ããŸãã
ãããŸã§ç§èªèº«ã
ãã©ã€ã¢ã¹ãã³ãããã£ãŒãã«ããŒã®ããã®ãµããªãšãã
æããŠããªãã£ãã®ãæ£çŽãªãšããã
ãã ãã¯ãªããã¯ã§ãäžçªããå°ãããã補åã®äžã€ã§ã
èªç¶ãšæèããããã«ãªã£ããæ°ã«ãªãæ é€çŽ ã®äžã€ã§ãã

1. ããããã¯ã¬ã¢ãã³ã£ãŠããã€ãã話é¡ã«ãªã£ãã®ïŒ
ã¯ã¬ã¢ãã³ãšããååèªäœã¯1832幎ã
ãã©ã³ã¹ã®ååŠè
ãçèããåãåºããããšã«ç±æ¥ããŸã
ïŒã®ãªã·ã£èªã§ãèããæå³ããèšèããïŒã
ãã ããµããªã¡ã³ããšããŠã®ã¯ã¬ã¢ãã³ããäžã«åºãŸã£ãã®ã¯ã
å®ã¯å²ãšæè¿ã®è©±ã
1992幎ãã«ã»ãããªãªã³ããã¯ããã£ããã§ããã
100méã¡ããªã¹ãã®ãªã³ãã©ãŒãã»ã¯ãªã¹ãã£éžæãã¯ããã
è±åœã®ãããã¢ã¹ãªãŒããã¡ã
ã¯ã¬ã¢ãã³ã䜿ã£ãŠããããšãå ±ããããäžæ°ã«æ³šç®ãéããã®ã§ãã
1996幎ã¢ãã©ã³ã¿äºèŒªã®é ã«ã¯ã
åºå Žéžæã®8å²ä»¥äžã䜿çšããŠãããšãèšãããã»ã©ã®åºããã§ããã
ã€ãŸãã¯ã¬ã¢ãã³ã¯ã決ããŠãæ°ããæµè¡ã®ãµããªãã§ã¯ãªãã
30幎以äžã®æŽå²ãšã
ãããè£ä»ããèšå€§ãªç ç©¶ã®èç©ãããæåãªãã§ããã
ããã¯æ£ã®åã§äžå®ããã«ãããŠããæ£è
ããã«ã
ãŸãäŒããããã€ã³ãã§ãã
2.ãç²åŽå埩ããšãçèã¥ããããå®ã¯ççŸããªã
åæã®ã¯ã¬ã¢ãã³ç ç©¶ã§ã¯
ãç²åŽå埩ããç¬çºåã¢ããããšããæèã§èªãããããšãå€ãã
æè¿ã¯ãçèã¥ããã®ãµããŒãããšãã説æã
ããè³ã«ããããã«ãªããŸããã
ãïŒçèã®ç°åãšååãåæã«èµ·ããâŠïŒãš
äžç¬ççŸããŠããããã«æãããããããŸãããã
éããã§ãã
ã¯ã¬ã¢ãã³ã¯çèã®äžã§
ãã¹ãã¯ã¬ã¢ãã³ïŒPCr) ãšãã圢ã§è²¯èµããã
äœããšãã«ã®ãŒïŒATPïŒãçŽ æ©ãäœãçŽãããã®
"äºåããããªãŒ"ã®ãããªåœ¹å²ãæãããŸãã
ã¯ã¬ã¢ãã³ãçŽæ¥ã¿ã³ãã¯è³ªåæãä¿é²ããŠããããã§ã¯ãªãã
PCrãã¹ãã¯ã¬ã¢ãã³ã«ããATPã®å³æååæãšããã
ãã£ãäžã€ã®ä»çµã¿ãã
ããã®å ŽïŒæ°ç§ãæ°åç§ïŒã§ã®ããã©ãŒãã³ã¹ç¶æããš
ãç©ã¿éãªã£ãçµæãšããŠã®çèã¥ããããšããã
æé軞ã®éã2ã€ã®çŸãæ¹ãããŠããã ããªãã§ãã
èŠã¯
ç¬çºçã«åãåºãåããããªåããæ¯ããé¢ïŒïŒç²åŽå埩çãªåŽé¢ïŒãšã
ç¶ç¶çãªçãã¬ã«ãã£ãŠ
çèãåŒãç· ãŸã£ãäœã¥ãããåŸæŒãããé¢ïŒïŒçèã¥ããã®åŽé¢ïŒ
åãã¡ã«ããºã ã®2ã€ã®çŸãæ¹ãããŠããŠ
ãå埩ããšãåæããã©ã¡ããæ ¹ã£ãã¯
"现èã®ãšãã«ã®ãŒäŸçµŠå"ã§ããïŒãšããããã§ãã

3. ã¯ã¬ã¢ãã³ãšã¯ã¬ã¢ããã³ãååã䌌ãŠããã©å¥ãã®
ã¯ãªããã¯ã§ãããæ··åãããã倧äºãªãã€ã³ãã§ãã
ã¯ã¬ã¢ãã³ïŒèèã»è èã»èµèã§3ã€ã®ã¢ããé žïŒã¢ã«ã®ãã³ãã°ãªã·ã³ãã¡ããªãã³ïŒããäœãããç©è³ªãçèã®äžã§ãšãã«ã®ãŒãäœãããã®"çæ"ã
ã¯ã¬ã¢ããã³ïŒã¯ã¬ã¢ãã³ãçèå ã§èªç¶ã«åè§£ãããŠã§ãã代è¬ã®çããããè èããææ³ãããã®ã§ãè¡æ¶²æ€æ»ã§ã®è æ©èœè©äŸ¡ã®ææšã«äœ¿ãããŸãã
ã€ãŸããçæãšãã®çãããã®é¢ä¿ã
ã¯ã¬ã¢ãã³ãå€ãæããšã代è¬ã®çµæãšããŠ
ã¯ã¬ã¢ããã³å€ããããã«äžããããšããããŸããã
ããã¯è
æ©èœãæªããªã£ããšããæå³ã§ã¯ãããŸããã
è¡æ¶²æ€æ»ã®æ°å€ã ããèŠãŠäžå®ã«ãªãåã«ã
ãçèéãå€ãæ¹ãã¯ã¬ã¢ãã³æåäžã®æ¹ã¯ãã¯ã¬ã¢ããã³ãããé«ãã«åºãããšãããããšç¥ã£ãŠãããšããã§ãããã

4. æåã¿ã€ãã³ã°ã¯ãéååïŒåŸïŒããããæ¯æ¥ç¶ããããšã
è¬å±ã§äžçªããèããã質åãããã§ãã
ããããã€ã³ã¯é£²ãã§ããã©ãã¯ã¬ã¢ãã³ã£ãŠãã€é£²ãã°ããã®ïŒã
çµè«ããèšããšãã¿ã€ãã³ã°ãããæ¯æ¥ç¶ç¶ããããšã®æ¹ããã£ãšå€§äºããšããã®ãææ°ã®ç ç©¶ã®ã³ã³ã»ã³ãµã¹ã§ãã
éåçŽåŸã®æåããããã«æå©ãšããå ±åãããäžæ¹ã
éåååŸã§ã®å·®ã¯ã»ãšãã©ãªãã
ãããã¯çµ±èšçã«ææã§ã¯ãªããšããç ç©¶ã®æ¹ãå€ãã®ã宿
ã
çç±ã¯ã·ã³ãã«ã§ã
飲ãã ã¯ã¬ã¢ãã³ãèè
žããåžåãããŠè¡äžã§ããŒã¯ã«éãããŸã§
60ã90åãçèãžã®åã蟌ã¿ã¯ããã«æ°æéããããŸãã
ã€ãŸãã
éåã®çŽåçŽåŸã«é£²ãã ã¯ã¬ã¢ãã³ã¯
ããã®æ¥ã®éåãã«ã¯éã«åããã
ç¿æ¥ä»¥éã®"貯é"ã«ç©ã¿ç«ãŠãããŠãã
ãšããã®ãå®éã®ãšããã
ãªã®ã§ç§ããã®ã¢ããã€ã¹ãšããŠã¯ã
ããããã€ã³ã·ã§ã€ã¯ã®ã€ãã§ã§å€§äžå€«ãå¿ããã«æ¯æ¥é£²ããæéãéžãã§ãã ããããšããã·ã³ãã«ãªçãã«èœã¡çããŸãã
5. åæéžã³ã®è©± â ãªãããã€ã補ããç®å°ã«ãªãã®ã
æ£ãèŠãŠãããšãCreapure®ããšãããã€ã補ã®è¡šèšãã
ãMONOãããšãã£ãåååã®è£œåãªã©ã
ãããããªã¯ã¬ã¢ãã³ã䞊ãã§ããŸãã
ã¡ãªã¿ã«ãMONOãã¯ãã¢ããã€ãã¬ãŒãïŒäžæ°Žåç©ïŒãã®ç¥ã
æåã§ããåç£åœãåæã®åºæã¯ã
ããã±ãŒãžã®å¥ã®ç®æïŒåç£åœè¡šç€ºãæå衚ïŒã§ç¢ºèªããå¿
èŠããããŸãã
ããã¯å質ã®èгç¹ããå°ãäžå¯§ã«èª¬æããããšããã§ãã
ã¯ã¬ã¢ãã³ã¯èªç¶çããã®æœåºã§ã¯ãªãã
ååŠåæã«ãã£ãŠäœãããæåã§ãã
ãã®ãããåæã®çŽåºŠã¯ãã©ãã§ãã©ãäœãããããã«
倧ããå·Šå³ãããŸãã
ãã€ãã®AlzChem瀟ã補é ããCreapure®ã¯ã
å°çšã®ééçç£ã©ã€ã³ã§ã
åæã®åãå
¥ãããæ¢±å
ãŸã§
ä»ã®è£œåãšå®å
šã«éé¢ãããå·¥çšã§äœãããŠããŸãã
ããã«ãããå€éšããã®æ··å
¥ãªã¹ã¯ãç©ççã«æã¡ã
ãããããšã®çŽåºŠæ€æ»ïŒHPLCåæïŒã§ãã¬ãŒãµããªãã£ã確ä¿ãããŠããããšãã£ãç¹åŸŽããããŸãã
åæéçšã®ãDCDããDHTãã£ãŠäœïŒ
ã¯ã¬ã¢ãã³ãåæããéçšã§ã¯ã
粟補ãäžååã ãš**DCDïŒãžã·ã¢ã³ãžã¢ããïŒã
DHTïŒãžãããããªã¢ãžã³ïŒ**ãšãã
å¯çæç©ãåŸ®éæ®ãããšããããŸãã
ããã¯ã¯ã¬ã¢ãã³ãã®ãã®ã§ã¯ãªãã
ããã°"äœãéçšã§åºãäœãæã"ã®ãããªãã®ã
åè³ªã®ææšã§ããããšã¯ç¢ºå®ã§ãããããå€ãïŒç²Ÿè£œãçãå®äŸ¡ãªåæããšãããµã€ã³ã«ãªããŸãã
ãããžã®å®å®³ã«ã€ããŠã¯ãDCDã¯EUã®èŠå¶åºæºïŒTDIïŒã«ç §ãããŠãéåžžã®æåéã§ã¯æ¥µããŠäœãæé²éã«ãšã©ãŸããšãããDHTã¯æ§é çã«äŒŒãç©è³ªã«çºããæ§ãææãããŠãããã®ã®ãDHTèªäœã®ããã§ã®æ¯æ§ããŒã¿ã¯ãŸã 確ç«ãããŠããŸããã
ã€ãŸããä»ããå±éºããšããããã
ãé¿ãããããã®ã¯ã§ããã ãé¿ããæ¹ãåççããšããã
å質管çãšããŠã®äºé²çãªè©±ã«ãªã£ãŠããŸãã
ã ããããã
çŽåºŠãæ°å€ã§ä¿èšŒããŠãããã©ã³ããéžã¶æå³ãããããšãããšã§ããã
ããã¯ã¯ã¬ã¢ãã³ã«éã£ã話ã§ã¯ãªãã
ãµããªã¡ã³ãå
šè¬ã«èšããããšã§ããããŸãã
âïžãããã€ã³ããŠããŒã®éé屿±æ
âïžããŒãæœåºç©ã®æ®ç蟲è¬
âïžé油系ãµããªã®é
žåãªã©ããã
ååŠåæãæœåºã»æ¿çž®ã®å·¥çšãçµãŠäœãããæ é€è£å©é£åã«ã¯ã
å€ããå°ãªããåãæ§é ã®åé¡ãã€ããŠãŸãããŸãã
ããªããã®æ é€çŽ ãå¿
èŠããã ãã§ãªãã
ãã©ãããæ¥ããã©ãäœãããæ é€çŽ ãããŸã§èŠãèŠç¹ã
ãããã第äžè
æ€æ»ãåãããã©ã³ããéžã¶ããšã®æ¬åœã®æå³ã ãšæã£ãŠããŸãã

ããããã¯ãç§ããã€ããäŒãããŠããããšããã³ã¹ã®éå±€ãã«æ²¿ã£ãŠæŽçããŸãã
â ãã§ã«ç¢ºç«ãããŠãã广 é«åŒ·åºŠã»çæééåã§ã®ããã©ãŒãã³ã¹åäžãã¬ãžã¹ã¿ã³ã¹ãã¬ãŒãã³ã°ãšã®çµã¿åããã«ããçåã»é€èèªéïŒèèªä»¥å€ã®äœçµæïŒã®å¢å ã
ããã¯30幎åã®ç ç©¶ã®èç©ããããæºãããŸããã
â¡ ææã ãããŸã çºå±éäž
ãã¬ã€ã³ãã©ã°ã»ç¡ç äžè¶³æã®èªç¥æ©èœïŒä»åã®ãªãŒã¹ãã©ãªã¢ã®ãã¥ãŒã¹ã§ã¯ããã¬ã€ã³ãã©ã°ãžã®å¹èœããšããŠããšããããããŠã¯ããŸãããããããããååæåãæ¥æ§ã®ç¡ç äžè¶³æã®èªç¥ããã©ãŒãã³ã¹ãæ¹åãããšããå ±åããåŸ¹å€æãã®ã¯ãŒãã³ã°ã¡ã¢ãªãŒã»æšè«èª²é¡ã®æçžŸåäžã瀺ããç ç©¶ãããäžæ¹ãå¥åº·ãªæäººã§ã®æ¥åžžçãªèªç¥æ©èœãžã®å¹æã¯ç ç©¶ããšã«ã°ãã€ãã倧ãããããã¬ã€ã³ãã©ã°ã®æ²»çããšèšãåããæ®µéã§ã¯ãããŸããã
ãã€çç¶ãžã®è£å©ïŒæãã€è¬ãšã®äœµçšã§çç¶æ¹åãæ©ãããšããå ±åãããäžæ¹ã忥µæ§éå®³ã®æ¹ã§ã¯èºè»¢ã®ãªã¹ã¯ãè æ©èœã«äžå®ãããæ¹ã§ã¯è² è·ãžã®æ³šæãå¿ èŠãšãããŠããŸãã
æŽå¹Žæå¥³æ§ãžã®å¿çšïŒå®å šæ§ã¯ç¢ºèªããã€ã€ãããŸãããå€§èŠæš¡è©Šéšã§ã¯éªšå¯åºŠãã®ãã®ãžã®æç¢ºãªæ¹åã¯èŠãããŠããããéªšã®æ§é ã®äžéšææšã«ãšã©ãŸããªã©ãã骚ã«å¹ãããšæå®ããã®ã¯ææå°æ©ã§ãã
⢠ãŸã 仮説段é Long COVIDãæ ¢æ§ç²åŽçå矀ã«é¢é£ãããã¬ã€ã³ãã©ã°ãžã®å¿çšãããžã¿ãªã¢ã³ã»ãŽã£ãŒã¬ã³ã§ã®è³å ã¯ã¬ã¢ãã³æ¿åºŠæ¹å广ãªã©ãçè«çãªè£ä»ãã¯ãã£ãŠããçŽæ¥çãªèšåºããŒã¿ã¯ãŸã éå®çã§ãã
å®å
šæ§ã«ã€ããŠã¯ãå¥åº·ãªæ¹ãæšå¥šçšéïŒ1æ¥3ã5gïŒãæãåã«ã¯ãè
æ©èœã»èæ©èœãžã®æªåœ±é¿ã¯ç¢ºèªãããŠããŸããã
ãã ãæ¢åã®è
çŸæ£ãããæ¹ã¯ãå¿
ã䞻治å»ã«çžè«ããŠããã ããããã€ã³ãã§ãã
7. ããããã¯ååæ é€åŠçãªèŠç¹ãã ããããããâ ã誰ã«ãã©ãã ããã®è©±
ãããŸã§ç ç©¶ããã©ã£ãŠããŠæ¹ããŠæããã®ã¯ã
ã¯ã¬ã¢ãã³ã®å¹æã¯ã
ãã®äººã®æ®æ®µã®é£ç掻ãäœèª¿ãšåãé¢ããªããšããããšã§ãã
åãéã®ã¯ã¬ã¢ãã³ãæã£ãŠãã
ããšããšèãéããã£ããé£ã¹ãŠããŠäœå ã¯ã¬ã¢ãã³è²¯èµéãååãªå¥åº·ãªæ¹
ããžã¿ãªã¢ã³ã»ãŽã£ãŒã¬ã³ããæ ¢æ§çãªç²åŽãç¡ç äžè¶³ãã¹ãã¬ã¹éå€ãªã©ã§çްèã®ãšãã«ã®ãŒä»£è¬ãã®ãã®ã匱ã£ãŠããæ¹
ãšã§ã¯ãäœæããæåŸ
ã§ããå€åã®å€§ãããããŸã£ããéã£ãŠããã¯ãã§ãã
ç ç©¶ã®äžã§ããç¡ç äžè¶³æãé«éœ¢è
ãããžã¿ãªã¢ã³ãªã©ãããšããšè²¯èµéãå°ãªãããããã¯ãšãã«ã®ãŒä»£è¬ãžã®è² è·ã倧ãã人ãã®æ¹ã广ãæãããããšããåŸåãç¹°ãè¿ãå ±åãããŠããã®ã¯ã
ãŸãã«ãã®åäœå·®ãè£ä»ããŠãããšæããŸãã
ããªããã®äººã¯ãã®æ é€çŽ ãäžè¶³ããŠããã®ãïŒã
ã¯ã¬ã¢ãã³ã"ã¿ããªã«å¹ãéæ³ã®ç²"ãšããŠç»äžçã«èªãã®ã§ã¯ãªãã
ãã®äººã®é£äºå
容ã代è¬ã®ç¶æ
ãã¹ãã¬ã¹è² è·ãèŠãäžã§ãå¿
èŠãªéãšã¿ã€ãã³ã°ãåå¥ã«èããã
ãããããããã ãµããªãå§ããã®ã§ã¯ãªããå 芳ãéããŠèªåã®äœãçè§£ããŠããããã»ã¹ã®å ¥ãå£ã«ãªãã®ã§ã¯ãªãããšæããŠããŸãã
æ¬èšäºã¯äžè¬çãªæ å ±æäŸãç®çãšãããã®ã§ãããåå¥ã®å»åŠçã¢ããã€ã¹ã«ä»£ãããã®ã§ã¯ãããŸãããæç ã®ããæ¹ãè¬ãæçšäžã®æ¹ã¯ãæååã«å»åž«ã«ãçžè«ãã ããã
åèæç®
Balsom PD, Soderlund K, Ekblom B.ãCreatine in humans with special reference to creatine supplementationãSports Medicine 1994ïŒPubMedïŒhttps://pubmed.ncbi.nlm.nih.gov/7817065/
Buford TW, et al.ãInternational Society of Sports Nutrition position stand: creatine supplementation and exerciseãJournal of the International Society of Sports Nutrition 2007ïŒPMCïŒhttps://pmc.ncbi.nlm.nih.gov/articles/PMC2048496/
Journal of Exercise and NutritionãTiming of Creatine Supplementation and Resistance Training: A Brief Reviewãhttps://www.journalofexerciseandnutrition.com/index.php/JEN/article/view/33
PMCãTiming of Creatine Supplementation around Exercise: A Real Concern?ãhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401986/
ScienceDirectãLevels of creatine, organic contaminants and heavy metals in creatine dietary supplementsãhttps://www.sciencedirect.com/science/article/abs/pii/S0308814610016377
Frontiers in NutritionïŒ2024ïŒãThe effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysisãhttps://doaj.org/article/b60a35d4b9c04eb2900550bdd1a8933d
PMCãCreatine Supplementation in Depression: A Review of Mechanisms, Efficacy, Clinical Outcomes, and Future Directionsãhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11567172/
PMCãCreatine in women's health: bridging the gap from menstruation through pregnancy to menopauseãhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC12086928/
ãA 2-yr Randomized Controlled Trial on Creatine Supplementation during Exercise for Postmenopausal Bone HealthãMedicine & Science in Sports & Exercise 2023ïŒPubMedïŒhttps://pubmed.ncbi.nlm.nih.gov/37144634/
Forbes SC, Chilibeck PD, Candow DG.ãCreatine Supplementation During Resistance Training Does Not Lead to Greater Bone Mineral Density in Older Humans: A Brief Meta-AnalysisãFrontiers in Nutrition 2018ïŒPMCïŒhttps://pmc.ncbi.nlm.nih.gov/articles/PMC5928444/
ãããªãšæã£ããå¿æŽãããïŒ
å¿æŽããŠããã ãããšå±ã¿ã«ãªããŸããããã ãããããã¯ãä»åŸã®æ
å ±çºä¿¡ãè³æåéã«æŽ»çšãããŠããã ããŸãã